Beyond receptor expression: The influence of receptor conformation, density, and affinity in HIV-1 infection

Virology

Volumn 276, Issue 2, 2000, Pages 229-237

  Doms, Robert W ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFORMATION; GENE EXPRESSION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEMBRANE FUSION; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR DENSITY; SHORT SURVEY; VIROGENESIS; VIRUS PATHOGENESIS; VIRUS TRANSMISSION;

EID: 0034715519     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0612     Document Type: Article

References (87)

1. CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1
2. A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV - Activity
3. HIV and SIV gp120 binding does not predict coreceptor function
4. Patterns of CCR5, CXCR4, and CCR3 usage by envelope glycoproteins from human immunodeficiency virus type 1 primary isolates
5. A new classification for HIV-1
6. Posttranslational oligomerization and cooperative acid activation of mixed influenza hemagglutinin trimers
7. Changes in human immunodeficiency virus type 1 envelope glycoproteins responsible for the pathogenicity of a multiply passaged simian-human immunodeficiency virus (SHIVHXBc2)
8. Core structure of gp41 from the HIV envelope glycoprotein
9. HIV entry and its inhibition
10. Natural infection of a homozygous delta-24 CCR5 red-capped mangabey with an R2b-tropic simian immunodeficiency virus
11. The orphan seven-transmembrane receptor Apj supports the entry of primary T-cell-line-tropic and dualtropic human immunodeficiency virus type 1
12. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
13. Change in coreceptor use correlates with disease progression in HIV-1 infected individuals
14. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene
15. Identification of a major co-receptor for primary isolates of HIV-1
16. Expression cloning of new receptors used by simian and human immunodeficiency viruses
17. HIV-1 tropism and coreceptor use
18. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor
19. Use of a gp120 binding assay to dissect the requirements and kinetics of human immunodeficiency virus fusion events
20. A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor
21. Identification of CXCR4 domains that support coreceptor and chemokine receptor functions
22. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors
23. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
24. Amino-terminal substitutions in the CCR5 co-receptor impair gp120 binding and human immunodeficiency virus type 1 entry
25. A binding pocket for a small molecule inhibitor of HIV entry within the transmembrane helices of CCR5
26. Inhibiting HIV-1 entry: Discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket
27. Functional dissection of CCR5 coreceptor function through the use of CD4-independent simian immunodeficiency virus strains
28. An orphan seven transmembrane domain receptor expressed widely in brain functions as a coreceptor for HIV-1 and SIV
29. Fusion of influenza hemagglutinin-expressing fibroblasts with glycophorin-bearing liposomes: Role of hemagglutinin surface density
30. Envelope glycoprotein determinants of increased fusogenicity in a pathogenic simian-human immunodeficiency virus (SHIV-KB9) passaged in vivo
31. Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection
32. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane domain, G-protein coupled receptor
33. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells
34. On the entry of Semliki Forest virus into BHK-21 cells
35. Virus-cell and cell-cell fusion
36. Use of a novel biosensor assay to measure ligand interactions with membrane proteins
37. Stable exposure of the coreceptor binding site in a CD4-independent HIV-1 envelope protein
38. Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into celt lines expressing CD4, CXCR4, and/or CCR5
39. The envelope glycoprotein ectodomains determine the efficiency of CD4+ T lymphocyte depletion in simian-human immunodeficiency virus-infected macaques
40. Membrane fusion and the alphavirus life cycle
41. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry
42. Adaptation of a CCR5 using primary HIV-1 isolate for CD4-independent replication
43. Cooperation of multiple CCR5 coreceptors is required for infections by human immunodeficiency virus type I
44. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
45. Determinants of CD4-independence for HIV-1/IIIBx map outside regions required for coreceptor specificity
46. Evidence for cell-surface association between Fusin and the CD4-gp120 complex in human cell lines
47. HIV requires multiple gp120 molecules for CD4-mediated infection
48. Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function
49. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages
50. CCR8 on human thymocytes functions as a human immunodeficiency virus type 1 coreceptor
51. Determination of the antibody binding capacity of lymphocyte membrane antigens by flow cytometry in 58 blood donors
52. STRL33, a novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1
53. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
54. Derivation and biological characterization of a molecular clone of SHIV KU-2 that causes AIDS, neurological disease, and renal disease in rhesus macaques
55. Inhibition of human immunodeficiency virus fusion by a monoclonal antibody to a coreceptor (CXCR4) is both celt type and virus strain dependent
56. The transition of HIV-1 gp41 into a six-helix bundle configuration induces membrane fusion
57. Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans
58. Simple methods for monitoring HIV-1 and HIV-2 gp120 binding to soluble CD4 by enzyme-linked immunosorbent assay: HIV-2 has a 25-fold lower affinity than HIV-1 for soluble CD4
59. Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates
60. Characterization of recombinant gp120 and gp160 from HIV-1: Binding to monoclonal antibodies and soluble CD4
61. Promonocytic U937 subclones expressing CD4 and CXCR4 are resistant to infection with and cell-to-cell fusion by T-cell-tropic human immunodeficiency virus type 1
62. A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection
63. Effects of CCR5 and CD4 cell surface concentrations by macrophage-tropic isolates of human immunodeficiency virus type 1
64. Expression and coreceptor function of APJ for primate immunodeficiency viruses
65. Role of CCR5 in infection of primary macrophages and lymphocytes by macrophage-tropic strains of human immunodeficiency virus: Resistance to patient-derived and prototype isolates resulting from the Δccr5 mutation
66. CD4-independent infection by HIV-2 (ROD/B): Use of the 7-transmembrane receptors CXCR-4, CCR-3, and V28 for entry
67. An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys
68. A role for carbohydrates in immune evasion in AIDS
69. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding
70. Utilization of chemokine receptors, orphan receptors, and herpesvirus encoded receptors by diverse human and simian immunodeficiency viruses
71. ChemR23, a putative chemoattractant receptor, is expressed in dendritic cells and is a coreceptor for SIV and some primary HIV-1 strains
72. Resistance to HIV-1 infection of Caucasian individuals bearing mutant alleles of the CCR5 chemokine receptor gene
73. In vivo evolution of HIV-1 coreceptor usage and sensitivity to chemokine-mediated suppression
74. Human immunodeficiency virus type 1 T-lymphotropic strains enter macrophages via a CD4- and CXCR4-mediated pathway: Replication is restricted at a postentry level
75. Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4
76. Expression and coreceptor activity of STRL33 on primary peripheral blood lymphocytes
77. Determinants of syncytium formation in microglia by human immunodeficiencyvirus type 1: Role of the V1/V2 domains
78. CXCR4 as a functional coreceptor for human immunodeficiency virus type 1 infection of primary macrophages
79. Coiled coils in both intracellular and viral membrane fusion
80. CD4-dependent, antibody-sensitive interactions between HIV-1 and its coreceptor CCR-5
81. CXCR-4 is a functional coreceptor for infection of human macrophages by CXCR4-dependent primary HIV-1 isolates
82. Atomic structure of the ectodomain from HIV-1 gp41
83. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5
84. The HIV-1 envelope glycoproteins: Fusogens, antigens, and immunogens
85. CXCR4 is expressed by primary macrophages and supports CCR5-independent infection by dual-tropic but not T-tropic isolates of HIV-1
86. Use of coreceptors other than CCR5 by non-syncytium-inducing adult and pediatric isolates of human immunodeficiency virus type 1 is rare in vitro